Iovance Biotherapeutics Inc
IOVA
Market Cap$594.4M
Close$
$-0.10
105.7% downside
Current Fair Value
105.7% downsideOvervalued by 105.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $594.40 Million |
|---|---|
| Enterprise Value | $476.45 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-1.28 |
| Beta | 1.06 |
| Outstanding Shares | 322,868,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -1.53 |
|---|---|
| PEG | 5.76 |
| Price to Sales | - |
| Price to Book Ratio | 0.89 |
| Enterprise Value to Revenue | 5.24 |
| Enterprise Value to EBIT | -1.11 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0.11 |
| Debt to Equity | 0.07 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Iovance Biotherapeutics Inc
CEO: Maria Fardis